miR-17–92 cluster was frequently amplified or overexpressed in CML CD34+ cells and abnormal expression of miR-17–92 greatly increased proliferation of CML stem cells [11]. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.